Nathan Steinle

Pegcetacoplan for the treatment of geographic atrophy secondary to age-related macular degeneration (OAKS and DERBY): two multicentre, randomised, double-masked, sham-controlled, phase 3 trials

Jeffrey S. Heier, Eleonora M. Lad, Frank G. Holz et al. · The Lancet · 2023 · 372 citations

Ocular Disease, Ophthalmology, Age-related Diseases +4

Systemic pharmacokinetics following intravitreal injections of ranibizumab, bevacizumab or aflibercept in patients with neovascular AMD

Robert L. Avery, Alessandro Castellarin, Nathan Steinle et al. · British Journal of Ophthalmology · 2014 · 362 citations · Full text

SYSTEMIC PHARMACOKINETICS AND PHARMACODYNAMICS OF INTRAVITREAL AFLIBERCEPT, BEVACIZUMAB, AND RANIBIZUMAB

Robert L. Avery, Alessandro Castellarin, Nathan Steinle et al. · Retina · 2017 · 318 citations · Full text

Faricimab Treat-and-Extend for Diabetic Macular Edema

Tien Yin Wong, Zdenka Hašková, Kemal Asik et al. · Ophthalmology · 2023 · 105 citations · Full text

Faricimab Treat-and-extend, Diabetic Retinopathy, Ocular Disease +3

Anti–Vascular Endothelial Growth Factor Therapy for Diabetic Retinopathy: Consequences of Inadvertent Treatment Interruptions

Thomas J. Wubben, Mark W. Johnson, Elliott H. Sohn et al. · American Journal of Ophthalmology · 2019 · 77 citations

Diabetic Retinopathy, Ocular Disease, Inadvertent Treatment Interruptions +8